Education
About Us
Working with TipRanks
Follow Us
Standard BioTools (LAB)
NASDAQ:LAB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 174.43M | $ 106.34M | $ 97.95M | $ 130.58M | $ 138.14M |
| Gross Profit | $ 84.26M | $ 50.45M | $ 37.05M | $ 69.37M | $ 83.33M |
| Operating Income | $ -175.24M | $ -76.60M | $ -116.20M | $ -67.46M | $ -51.04M |
| EBITDA | $ -118.14M | $ -54.46M | $ -173.57M | $ -43.77M | $ -32.59M |
| Net Income | $ -138.88M | $ -74.66M | $ -190.10M | $ -59.24M | $ -53.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 292.87M | $ 114.89M | $ 165.78M | $ 28.45M | $ 68.52M |
| Total Assets | $ 612.34M | $ 323.07M | $ 390.31M | $ 275.21M | $ 324.76M |
| Total Debt | $ 33.00M | $ 98.21M | $ 102.66M | $ 111.65M | $ 95.38M |
| Net Debt | $ -133.73M | $ 46.51M | $ 21.35M | $ 83.20M | $ 26.86M |
| Total Liabilities | $ 140.62M | $ 159.87M | $ 471.78M | $ 180.62M | $ 185.71M |
| Stockholders' Equity | $ 471.72M | $ 163.20M | $ 229.79M | $ 94.60M | $ 139.05M |
| Cash Flow | |||||
| Free Cash Flow | $ -151.81M | $ -46.12M | $ -93.19M | $ -57.33M | $ -28.13M |
| Operating Cash Flow | $ -143.45M | $ -43.29M | $ -89.37M | $ -44.06M | $ -15.42M |
| Investing Cash Flow | $ 363.17M | $ 20.24M | $ -88.13M | $ -11.95M | $ 39.98M |
| Financing Cash Flow | $ -102.62M | $ -6.81M | $ 230.76M | $ 15.96M | $ 20.86M |